Search

everythinglearnresearchcommunity

for

Search:↓

Research on the human skin microbiome has grown, focusing on skin health and diseases, with more studies needed on antibiotic resistance and AI applications.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

Early exposure to germs may protect against autoimmune diseases, lack of sex increases alcohol preference in fruit flies, a potential baldness treatment could involve blocking a specific receptor, skin memory cells help prevent re-infection, high-fat diets can affect brain cells related to weight, and the link between social status, stress, and heart disease in primates is unclear.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

The skin and thymus develop similarly to protect and support immunity.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Tiny particles from skin cells can help activate hair growth.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Targeting Vδ1+T-cells may help treat alopecia areata.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

Choosing the right method to separate skin layers is key for good skin cell research.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.